{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T23:45:57Z","timestamp":1770680757038,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Rarecells Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Myelodysplastic syndromes (MDS) are incurable diseases characterized by dysplastic hematopoietic cells, cytopenias in the blood and an inherent tendency for transformation to secondary acute myeloid leukemia (AML). Since most therapies fail to prevent rapid clonal evolution and disease resistance, new and non-invasive predictive markers are needed to monitor patients and adapt the therapeutic strategy. By using ISET, a very sensitive approach to isolate cells larger than mature leukocytes from peripheral blood samples, we looked for cellular markers in 99 patients (158 samples) with MDS and 66 healthy individuals (76 samples) used as controls. We found a total of 680 Giant Cells, defined as cells having a size of 40 microns or larger in 46 MDS patients (80 samples) and 28 Giant Cells in 11 healthy individuals (11 samples). In order to understand if we had enriched from peripheral blood atypical cells of the megakaryocyte line, we studied the Giant Cells using immunolabeling with megakaryocytes and tumor-specific markers. We report that the Giant Cells we found in the peripheral blood of MDS patients primarily express tumor markers. Our results show that Polyploid Giant Cancer Cells (PGCC), similar to those described in solid tumors, are found in the peripheral blood of patients with MDS and suggest the working hypothesis that they could play a role in hematological malignancies.<\/jats:p>","DOI":"10.1007\/s12032-023-02064-z","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T16:01:50Z","timestamp":1686758510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Circulating cancer giant cells with unique characteristics frequently found in patients with myelodysplastic syndromes (MDS)"],"prefix":"10.1007","volume":"40","author":[{"given":"Abdullah Mahmood","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"BenMohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Decina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley","family":"Levi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura Nalleli","family":"Garrido Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Br\u00e9chot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Jurcic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9734-5210","authenticated-orcid":false,"given":"Azra","family":"Raza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7981-6325","authenticated-orcid":false,"given":"Patrizia","family":"Paterlini Br\u00e9chot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"2064_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2021.10.006","volume":"81","author":"J Liu","year":"2022","unstructured":"Liu J, Erenpreisa J, Sikora E. Polyploid giant cancer cells: an emerging new field of cancer biology. Semin Cancer Biol. 2022;81:1\u20134.","journal-title":"Semin Cancer Biol"},{"key":"2064_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s12032-022-01652-9","volume":"39","author":"S Mukherjee","year":"2022","unstructured":"Mukherjee S, Ali AM, Murty VV, Raza A. Mutation in SF3B1 gene promotes formation of polyploid giant cells in leukemia cells. Med Oncol. 2022;39:65.","journal-title":"Med Oncol"},{"key":"2064_CR3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/onc.2013.96","volume":"33","author":"S Zhang","year":"2014","unstructured":"Zhang S, Mercado-Uribe I, Xing Z, Sun B, Kuang J, Liu J. Generation of cancer stem-like cells through the formation of polyploid giant cancer cells. Oncogene. 2014;33:116\u201328.","journal-title":"Oncogene"},{"key":"2064_CR4","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1111\/eva.12929","volume":"13","author":"KJ Pienta","year":"2020","unstructured":"Pienta KJ, Hammarlund EU, Axelrod R, Brown JS, Amend SR. Poly-aneuploid cancer cells promote evolvability, generating lethal cancer. Evol Appl. 2020;13:1626\u201334.","journal-title":"Evol Appl"},{"key":"2064_CR5","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.1038\/onc.2017.72","volume":"36","author":"N Niu","year":"2017","unstructured":"Niu N, Mercado-Uribe I, Liu J. Dedifferentiation into blastomere-like cancer stem cells via formation of polyploid giant cancer cells. Oncogene. 2017;36:4887\u2013900.","journal-title":"Oncogene"},{"key":"2064_CR6","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.jtho.2020.04.034","volume":"15","author":"Y Manjunath","year":"2020","unstructured":"Manjunath Y, Mitchem JB, Suvilesh KN, Avella DM, Kimchi ET, Staveley-O\u2019Carroll KF, et al. Circulating giant tumor-macrophage fusion cells are independent prognosticators in patients with NSCLC. J Thorac Oncol. 2020;15:1460\u201371.","journal-title":"J Thorac Oncol"},{"issue":"5","key":"2064_CR7","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.3390\/ijms21051872","volume":"21","author":"Y Manjunath","year":"2020","unstructured":"Manjunath Y, Porciani D, Mitchem JB, Suvilesh KN, Avella DM, Kimchi ET, et al. Tumor-cell-macrophage fusion cells as liquid biomarkers and tumor enhancers in cancer. Int J Mol Sci. 2020;21(5):1872.","journal-title":"Int J Mol Sci"},{"key":"2064_CR8","doi-asserted-by":"publisher","first-page":"eaat7828","DOI":"10.1126\/sciadv.aat7828","volume":"4","author":"CE Gast","year":"2018","unstructured":"Gast CE, Silk AD, Zarour L, Riegler L, Burkhart JG, Gustafson KT, et al. Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival. Sci Adv. 2018;4:eaat7828.","journal-title":"Sci Adv"},{"key":"2064_CR9","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1158\/0008-5472.CAN-10-3223","volume":"71","author":"AE Powell","year":"2011","unstructured":"Powell AE, Anderson EC, Davies PS, Silk AD, Pelz C, Impey S, et al. Fusion between Intestinal epithelial cells and macrophages in a cancer context results in nuclear reprogramming. Cancer Res. 2011;71:1497\u2013505.","journal-title":"Cancer Res"},{"key":"2064_CR10","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jcmgh.2019.07.002","volume":"8","author":"TL Sutton","year":"2019","unstructured":"Sutton TL, Walker BS, Wong MH. Circulating hybrid cells join the fray of circulating cellular biomarkers. Cell Mol Gastroenterol Hepatol. 2019;8:595\u2013607.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2064_CR11","doi-asserted-by":"publisher","first-page":"8567","DOI":"10.1245\/s10434-021-10379-2","volume":"28","author":"BS Walker","year":"2021","unstructured":"Walker BS, Sutton TL, Zarour L, Hunter JG, Wood SG, Tsikitis VL, et al. Circulating hybrid cells: a novel liquid biomarker of treatment response in gastrointestinal cancers. Ann Surg Oncol. 2021;28:8567\u201378.","journal-title":"Ann Surg Oncol"},{"key":"2064_CR12","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1073\/pnas.1320198111","volume":"111","author":"DL Adams","year":"2014","unstructured":"Adams DL, Martin SS, Alpaugh RK, Charpentier M, Tsai S, Bergan RC, et al. Circulating giant macrophages as a potential biomarker of solid tumors. Proc Natl Acad Sci U S A. 2014;111:3514\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2064_CR13","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1158\/1055-9965.EPI-15-1221","volume":"25","author":"DL Adams","year":"2016","unstructured":"Adams DL, Adams DK, Alpaugh RK, Cristofanilli M, Martin SS, Chumsri S, et al. Circulating cancer-associated macrophage-like cells differentiate malignant breast cancer and benign breast conditions. Cancer Epidemiol Biomarkers Prev. 2016;25:1037\u201342.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2064_CR14","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1365-2141.1991.tb08618.x","volume":"77","author":"KF Wong","year":"1991","unstructured":"Wong KF, Chan JK. Are \u2018dysplastic\u2019 and hypogranular megakaryocytes specific markers for myelodysplastic syndrome. Br J Haematol. 1991;77:509\u201314.","journal-title":"Br J Haematol"},{"key":"2064_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169427","volume":"12","author":"S Laget","year":"2017","unstructured":"Laget S, Broncy L, Hormigos K, Dhingra DM, BenMohamed F, Capiod T, et al. Technical insights into highly sensitive isolation and molecular characterization of fixed and live circulating tumor cells for early detection of tumor invasion. PLoS ONE. 2017;12: e0169427.","journal-title":"PLoS ONE"},{"key":"2064_CR16","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1182\/blood-2017-08-803635","volume":"130","author":"NK Ku","year":"2017","unstructured":"Ku NK, Rashidi H. Unusual finding of a megakaryocyte in a peripheral blood smear. Blood. 2017;130:2573.","journal-title":"Blood"},{"key":"2064_CR17","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s12185-019-02752-5","volume":"110","author":"T Nakai","year":"2019","unstructured":"Nakai T, Okamoto Y. A megakaryocyte in a peripheral blood smear. Int J Hematol. 2019;110:647.","journal-title":"Int J Hematol"},{"key":"2064_CR18","first-page":"212","volume":"36","author":"N Garg","year":"2019","unstructured":"Garg N, Gupta RJ, Kumar S. Megakaryocytes in peripheral blood smears. Turk J Haematol. 2019;36:212\u20133.","journal-title":"Turk J Haematol"},{"key":"2064_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s40001-022-00787-9","volume":"27","author":"G Li","year":"2022","unstructured":"Li G, Wang B, Li D, Zhu R, Chen X. Markedly increased small-sized megakaryocytes and platelets count in the circulation with pseudo-hyperkalemia following splenectomy. Eur J Med Res. 2022;27:155.","journal-title":"Eur J Med Res"},{"key":"2064_CR20","doi-asserted-by":"publisher","first-page":"E828","DOI":"10.1073\/pnas.1215787110","volume":"110","author":"G Cornelis","year":"2013","unstructured":"Cornelis G, Heidmann O, Degrelle SA, Vernochet C, Lavialle C, Letzelter C, et al. Captured retroviral envelope syncytin gene associated with the unique placental structure of higher ruminants. Proc Natl Acad Sci U S A. 2013;110:E828\u201337.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2064_CR21","doi-asserted-by":"publisher","first-page":"20120507","DOI":"10.1098\/rstb.2012.0507","volume":"368","author":"C Lavialle","year":"2013","unstructured":"Lavialle C, Cornelis G, Dupressoir A, Esnault C, Heidmann O, Vernochet C, et al. Paleovirology of \u2018syncytins\u2019, retroviral env genes exapted for a role in placentation. Philos Trans R Soc Lond B Biol Sci. 2013;368:20120507.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2064_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13073-016-0324-x","volume":"8","author":"MA Jafri","year":"2016","unstructured":"Jafri MA, Ansari SA, Alqahtani MH, Shay JW. Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies. Genome Med. 2016;8:69.","journal-title":"Genome Med"},{"key":"2064_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3343\/alm.2017.37.3.195","volume":"37","author":"HS Park","year":"2017","unstructured":"Park HS, Choi J, See CJ, Kim JA, Park SN, Im K, et al. Dysregulation of telomere lengths and telomerase activity in myelodysplastic syndrome. Ann Lab Med. 2017;37:195\u2013203.","journal-title":"Ann Lab Med"},{"key":"2064_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s40364-022-00426-9","volume":"10","author":"DY Shin","year":"2022","unstructured":"Shin DY, Lim KM, Park HS, Kwon S, Yoon SS, Lee DS. The importance of critically short telomere in myelodysplastic syndrome. Biomark Res. 2022;10:79.","journal-title":"Biomark Res"},{"key":"2064_CR25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1136\/jcp.2007.054353","volume":"62","author":"AM Florena","year":"2009","unstructured":"Florena AM, Tripodo C, Di Bernardo A, Iannitto E, Guarnotta C, Porcasi R, et al. Different immunophenotypical apoptotic profiles characterise megakaryocytes of essential thrombocythaemia and primary myelofibrosis. J Clin Pathol. 2009;62:331\u20138.","journal-title":"J Clin Pathol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-023-02064-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-023-02064-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-023-02064-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T21:20:01Z","timestamp":1687900801000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-023-02064-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,14]]},"references-count":25,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["2064"],"URL":"https:\/\/doi.org\/10.1007\/s12032-023-02064-z","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,14]]},"assertion":[{"value":"18 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AR received funding from Rarecells. AMA and AR are co-inventors on a pending patent application describing the targeting of giant and or hybrid cells. The pending patent application is licensed to TFC Therapeutics. AMA and AR have equity interest and are consultants in TFC Therapeutics. PPB is inventor on a pending patent application describing companion diagnostic biomarkers on circulating cancer giant cells and of ISET technology; she is President of Rarecells Inc and Rarecells Diagnostics with equity interests in Rarecells. FBM, AD, LNGC, DB are employees of Rarecells Diagnostics. All other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study is approved by the institutional review board of Columbia University Irving Medical Center under IRB protocol AAAR7591 and is performed in accordance with the declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"204"}}